0001477449-24-000046.txt : 20240305 0001477449-24-000046.hdr.sgml : 20240305 20240305161016 ACCESSION NUMBER: 0001477449-24-000046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verstraete Stephany CENTRAL INDEX KEY: 0001726419 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 24720412 MAIL ADDRESS: STREET 1: C/O TELADOC, INC. STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 wk-form4_1709672996.xml FORM 4 X0508 4 2024-03-01 0 0001477449 Teladoc Health, Inc. TDOC 0001726419 Verstraete Stephany C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 CHIEF MARKETING OFFICER 0 Common Stock 2024-03-01 4 M 0 4437 A 47554 D Common Stock 2024-03-01 4 M 0 437 A 47991 D Common Stock 2024-03-01 4 M 0 867 A 48858 D Common Stock 2024-03-01 4 M 0 1404 A 50262 D Common Stock 2024-03-01 4 M 0 13021 A 63283 D Common Stock 2024-03-01 4 M 0 1148 A 64431 D Common Stock 2024-03-04 4 S 0 7945 14.516 D 56486 D Performance Stock Units 2024-03-01 4 A 0 13313 0 A Common Stock 13313 13313 D Performance Stock Units 2024-03-01 4 M 0 4437 0 D Common Stock 4437 8876 D Performance Stock Units 2024-03-01 4 M 0 437 0 D Common Stock 437 0 D Performance Stock Units 2024-03-01 4 M 0 867 0 D Common Stock 867 0 D Restricted Stock Units 2024-03-01 4 M 0 1404 0 D Common Stock 1404 5616 D Restricted Stock Units 2024-03-01 4 M 0 13021 0 D Common Stock 13021 26042 D Restricted Stock Units 2024-03-01 4 M 0 1148 0 D Common Stock 1148 0 D Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. /s/ Adam C. Vandervoort, Attorney-in-Fact 2024-03-05